Cleansing Notice
Released
Released
Announcement PDF
ASX Announcement
28 October 2026
JOIN MICROBA’S INTERACTIVE INVESTOR HUB
For more Company information and to engage with management by asking questions about Microba’s latest announcements
and updates, visit ir.microba.com/welcome
Microba Life Sciences Ltd | ABN 82 617 096 652 | L10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621
Cleansing Notice under section 708A(5)(e) of the
Corporations Act
This notice is given by Microba Life Sciences Limited (ASX : MAP) (Microba or Company) under section
708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).
On 20 October 2026, Microba announced a capital raise to the ASX consisting of a two-tranche placement of
50,625,000 new fully paid ordinary shares at an issue price of $0.04 per ordinary share (Placement).
25,625,000 ordinary shares under tranche 1 of the Placement (Tranche 1 Placement Shares) were issued on 28
October 2026 and an Appendix 2A has been lodged with the ASX for quotation of those Tranche 1 Placement
Shares.
Details of the Tranche 1 Placement Shares
Class of Securities: Tranche 1 Placement Shares are fully paid ordinary shares
ASX Code of the securities: ASX : MAP
Date of the issue: 28 October 2026
Total number of Tranche 1 Placement Shares: 25,625,000
In accordance with section 708A(6) of the Corporations Act, Microba gives notice that:
• the Tranche 1 Placement Shares were issued without disclosure to investors under Part 6D.2 of the
Corporations Act;
• this notice is being given under section 708A(5)(e) of the Corporations Act;
• as of the date of this notice, the Company has complied with:
o the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and
o sections 674 and 674A of the Corporations Act; and
• as of the date of this notice, there is no "excluded information" as defined in sections 708A(7) and 708A(8) of
the Corporations Act which is required to be disclosed by the Company.
Authorised for release by the Board.
For further information, please contact:
Investor / Media Relations
investor@microba.com
https://ir.microba.com/welcome
About Microba Life Sciences Limited
Microba is at the forefront of microbiome health and human care. With world-leading science, insights and collaboration tools,
Microba's vision is to deliver clinical-grade microbiome tests that help people live healthier, happier lives. Better science. Better
insights. Better health. Microba – Expect better. www.microba.com
Share your feedback
Discover